GAMMA Investing’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.3K Buy
2,588
+433
+20% +$4.28K ﹤0.01% 2712
2026
Q1
$20.9K Buy
2,155
+1,645
+323% +$15.1K ﹤0.01% 2691
2025
Q4
$4.87K Buy
510
+124
+32% +$1.26K ﹤0.01% 3289
2025
Q3
$3.77K Buy
386
+189
+96% +$1.45K ﹤0.01% 3279
2025
Q2
$1.2K Sell
197
-288
-59% -$2.16K ﹤0.01% 3503
2025
Q1
$6K Buy
485
+358
+282% +$5.06K ﹤0.01% 3010
2024
Q4
$1.76K Buy
127
+60
+90% +$946 ﹤0.01% 3259
2024
Q3
$1.12K Sell
67
-300
-82% -$6.45K ﹤0.01% 3227
2024
Q2
$7.58K Buy
367
+309
+533% +$6.69K ﹤0.01% 2388
2024
Q1
$1.44K Buy
58
+18
+45% +$535 ﹤0.01% 2852
2023
Q4
$1.14K Buy
+40
New +$1.54K ﹤0.01% 2757

Other funds holding PRTA

GAMMA Investing's PRTA Position: Q2 2026 in Review

GAMMA Investing increased its Prothena Corp (PRTA) stake by 20% in Q2 2026, buying an estimated $4.28K and bringing the position to 2,588 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

GAMMA Investing first reported a position in PRTA in Q4 2023 and has held it in 11 quarters since. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • GAMMA Investing held 2,588 shares of Prothena Corp worth $25.3K as of Q2 2026.
  • GAMMA Investing bought 433 Prothena Corp shares in Q2 2026, an estimated $4.28K.
  • Prothena Corp made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2712 holding.
  • GAMMA Investing first reported a position in Prothena Corp in Q4 2023 and has held it in 11 quarters since.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.